We use cookies on our site to analyze traffic, enhance your experience, and provide you with tailored content.

For more information visit our privacy policy.

Common Contracts

3 similar Process Development and Manufacturing Services Agreement contracts by Proteon Therapeutics Inc

Process Development and Manufacturing Services Agreement by and between Proteon Therapeutics and Lonza Ltd
Process Development and Manufacturing Services Agreement • September 16th, 2014 • Proteon Therapeutics Inc • Biological products, (no disgnostic substances) • New York

This Process Development and Manufacturing Services Agreement (this “Agreement”) is effective as of September 1, 2009 (the “Effective Date”), by and between Proteon Therapeutics, a Delaware corporation, with an address at 200 West Street, Waltham, Massachusetts (“PROTEON”), and Lonza Ltd, a Swiss company with an address at Muenchensteinerstrasse 38, CH-4002 Basel, Switzerland (“LONZA”) (each, a “Party” and together the “Parties”).

Standard Contracts

Process Development and Manufacturing Services Agreement by and between Proteon Therapeutics and Lonza Ltd
Process Development and Manufacturing Services Agreement • August 26th, 2014 • Proteon Therapeutics Inc • Biological products, (no disgnostic substances) • New York

This Process Development and Manufacturing Services Agreement (this “Agreement”) is effective as of September 1, 2009 (the “Effective Date”), by and between Proteon Therapeutics, a Delaware corporation, with an address at 200 West Street, Waltham, Massachusetts (“PROTEON”), and Lonza Ltd, a Swiss company with an address at Muenchensteinerstrasse 38, CH-4002 Basel, Switzerland (“LONZA”) (each, a “Party” and together the “Parties”).

Process Development and Manufacturing Services Agreement by and between Proteon Therapeutics and Lonza Ltd
Process Development and Manufacturing Services Agreement • June 25th, 2014 • Proteon Therapeutics Inc • Biological products, (no disgnostic substances) • New York

This Process Development and Manufacturing Services Agreement (this “Agreement”) is effective as of September 1, 2009 (the “Effective Date”), by and between Proteon Therapeutics, a Delaware corporation, with an address at 200 West Street, Waltham, Massachusetts (“PROTEON”), and Lonza Ltd, a Swiss company with an address at Muenchensteinerstrasse 38, CH-4002 Basel, Switzerland (“LONZA”) (each, a “Party” and together the “Parties”).